SEME enables programmable transcript reconstruction through synthetic microexon incorporation
Precise correction of pathogenic mutations remains challenging for therapeutic applications because genome editing within protein-coding exons can generate unintended insertion-deletion byproducts that disrupt coding integrity and protein function. To address this limitation, we developed the Spliceable Editable Microexon Element (SEME), an intron-targeting platform that enables programmable…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
